|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Hexal_AG
gptkb:Eon_Labs
gptkb:Sandoz_Pharmaceuticals
|
|
gptkbp:awards
|
Innovation Awards
Sustainability Awards
Pharma Awards
Quality Awards
Best Employer Awards
|
|
gptkbp:clinicalTrials
|
ongoing
completed
phases I, II, III
FDA_approved
EMA_approved
|
|
gptkbp:employeeCount
|
over 10,000
|
|
gptkbp:founded
|
1886
|
|
gptkbp:founder
|
Emil_Barell
|
|
gptkbp:headquarters
|
gptkb:Holzkirchen,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sandoz Laboratories
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:market
|
gptkb:Asia
gptkb:Latin_America
gptkb:North_America
Africa
Europe
Middle_East
|
|
gptkbp:parentCompany
|
Novartis
|
|
gptkbp:partnerships
|
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Merck_&_Co.
gptkb:Amgen
|
|
gptkbp:partOf
|
Novartis Group
|
|
gptkbp:products
|
generic drugs
biosimilars
|
|
gptkbp:region
|
global
|
|
gptkbp:researchFocus
|
oncology
antibiotics
autoimmune diseases
central nervous system disorders
|
|
gptkbp:revenue
|
$10 billion (2020)
|
|
gptkbp:subsidiary
|
gptkb:Sandoz_UK_Ltd.
gptkb:Sandoz_Australia_Pty_Ltd.
gptkb:Sandoz_GmbH
gptkb:Sandoz_India_Ltd.
gptkb:Sandoz_Canada_Inc.
|
|
gptkbp:sustainabilityInitiatives
|
Diversity and Inclusion
Environmental Sustainability
Responsible Sourcing
Access_to_Medicines
Patient_Access_Programs
|
|
gptkbp:website
|
www.sandoz.com
|